<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0809211030
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2013
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        AUGMENTIN 1 G TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AMOXICILLIN,CLAVULANIC ACID
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        875,125
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        14
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        78.30
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SMIITHKLINE BEECHAM" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SMIITHKLINE BEECHAM
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01CR02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Augmentin is an antibiotic used in adults and children to treat infections in different parts of the body caused by certain types of bacteria.</p><p>Augmentin contains two different medicines called amoxicillin and clavulanic acid. Amoxicillin is a penicillin antibiotic. Amoxicillin can sometimes be stopped from working (made inactive). The other active medicine, clavulanic acid, stops this from happening.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Augmentin:&nbsp; </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you&rsquo;re allergic (hypersensitive) to amoxicillin, clavulanic acid, other penicillin-based antibiotics, or similar antibiotics called cephalosporins.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have ever had liver problems or jaundice (yellowing of the skin and/or whites of the eyes) when taking an antibiotic.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you think any of these apply to you, check with your doctor before you take Augmentin.</p><p>&nbsp;</p><p><strong>Take special care with Augmentin.</strong></p><p>Before you take Augmentin, your doctor needs to know:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have ever had an <strong>allergic</strong> <strong>reaction</strong> to any other antibiotics or medicines. This might include a skin rash or swelling of the face or neck.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have <strong>glandular fever </strong>(<strong>mononucleosis</strong>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you&rsquo;re taking medicines, such as warfarin, that are used to <strong>prevent blood clots</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have <strong>liver problems</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have <strong>kidney disease</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you&rsquo;re not <strong>urinating</strong> <strong>regularly </strong>or not able to <strong>drink</strong> very much.</p><p>&nbsp;</p><p>&egrave; <strong>Check with your doctor</strong> if you think any of these may apply to you. Your doctor will decide whether Augmentin is suitable for you and may need to adjust your dose or give you a different medicine.<strong> </strong></p><p>&nbsp;</p><p><strong>Look out for important symptoms.</strong></p><p>Augmentin can make some existing conditions worse, or cause serious side effects, such as <strong>severe allergic reactions, serious skin reactions, chest pain, </strong><strong>repetitive vomiting within 1 to 4 hours of Augmentin administration, </strong><strong>serious liver problems or severe diarrhoea </strong>or<strong> inflammation of the large intestines (pseudomembranous colitis)</strong>. You must look out for certain symptoms while you&rsquo;re taking Augmentin to help reduce the risk of any problems. See &lsquo;<em>Look out for important symptoms</em>&rsquo; in <strong>Section 4</strong>.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>While you&rsquo;re taking Augmentin&nbsp; </strong></p><p><strong>Other medicines and Augmentin&nbsp; </strong></p><p><strong>Tell your doctor or pharmacist if you&#39;re taking any other medicines</strong>, if you&rsquo;ve taken any recently, or if you start taking new ones. This includes medicines bought without a prescription.</p><p>Some medicines may affect how<strong><em> </em></strong>Augmentin works or make it more likely that you&rsquo;ll have side effects. Augmentin can also affect how some other medicines work. These include:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>probenecid</strong> and <strong>allopurinol</strong> (used to <strong>treat gout</strong>).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>anticoagulants</strong> (used to <strong>prevent blood clots</strong>) such as warfarin and acenocoumarol.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>mycophenolate</strong> <strong>mofetil</strong> (used to <strong>prevent the rejection of transplanted organs</strong>).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; methotrexate (used to treat conditions such as cancer and severe psoriasis).</p><p>&egrave; Tell your doctor or pharmacist if you&rsquo;re taking any of these.</p><p>&nbsp;</p><p>Augmentin may reduce how well the <strong>contraceptive pill</strong> works. If you&rsquo;re taking the contraceptive pill while you&rsquo;re being treated with Augmentin, you should also use a <strong>barrier method of contraception</strong> (such as condoms). Ask your doctor for advice.</p><p><strong>Pregnancy and breast-feeding&nbsp; </strong></p><p>If you&rsquo;re <strong>pregnant</strong>, or <strong>think you could be</strong>, or if you&rsquo;re <strong>planning to become pregnant</strong>, <strong>don&rsquo;t take Augmentin</strong> without checking with your doctor. <strong>Your doctor</strong> will consider the benefit to you and the risk to your baby of taking</p><p>Augmentin while you&rsquo;re pregnant.</p><p>You can usually breast-feed while you&rsquo;re taking Augmentin. If you&rsquo;re breastfeeding or considering breast-feeding, <strong>check with your doctor before you take Augmentin</strong>.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Augmentin exactly as your doctor has told you to. Check with your doctor or pharmacist if you&#39;re not sure.</p><p><strong>How much to take.</strong></p><p><strong>&nbsp;</strong>Your doctor will decide on the correct dosage for you.</p><p>&nbsp;</p><p><strong>Patients with kidney or liver problems </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have kidney problems, your doctor may give you a different strength or a different medicine.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have liver problems, you may have more frequent blood tests to check how your liver is working.</p><p><strong>How to take&nbsp; </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Take Augmentin at the start of a meal or slightly before.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swallow the tablets whole with a glass of water.</p><p>Do not take Augmentin for more than 14 days. If you still feel unwell you should go back to <strong>see your doctor.</strong></p><p><strong>&nbsp;</strong></p><p><strong>If you forget to take Augmentin&nbsp; </strong></p><p><strong>Don&#39;t take a double dose to make up for a missed dose</strong>. Just take it as soon as you remember.</p><p><strong>If you&rsquo;re not sure what to do,</strong> ask your doctor or pharmacist. <strong>If you take too much Augmentin&nbsp; </strong></p><p>If you accidently take<em> </em>too much Augmentin it is unlikely to cause any serious problems. The most common side effects of taking too much Augmentin are nausea, vomiting and diarrhoea. If you&rsquo;re worried, or you feel unwell:</p><p>&egrave;Ask your doctor or pharmacist for advice.</p><p><strong>Don&rsquo;t stop taking Augmentin without advice.&nbsp; </strong></p><p><strong>It is important that you take the full course of Augmentin</strong> Don&rsquo;t stop unless your doctor advises you to &ndash; even if you&rsquo;re feeling better. If you don&rsquo;t complete the full course of treatment, the infection may come back</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Augmentin can cause side effects, but not everybody gets them.</p><p><strong>Look out for important symptoms.&nbsp; </strong></p><p><strong>Severe allergic reactions </strong></p><p>These are very rare in people taking Augmentin. Signs include:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; raised, itchy rash (<em>hives</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of blood vessels (<em>vasculitis</em>) which may be visible as red or purple raised spots on the skin, but can affect other parts of the body.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever, joint pain, swollen glands in the neck, armpit or groin.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling, sometimes of the face or mouth (<em>angioedema</em>), which may cause difficulty in swallowing or breathing.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; collapse.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chest pain which can be a sign of a potentially serious allergic reaction called <em>Kounis syndrome</em>.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; repetitive vomiting (1 to 4 hours after <strong>Augmentin</strong> administration), stomach pain, abnormal drowsiness, diarrhoea and low blood pressure which can be a sign of a serious allergic reaction called <em>drug-induced enterocolitis syndrome</em>.</p><p>&egrave;<strong>Get medical help immediately</strong> if you get any of these symptoms. <strong>Stop taking Augmentin.</strong></p><p><strong>Serious skin reactions </strong></p><p>These are rare in people taking Augmentin. Signs include:</p><p>skin rash, which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge &ndash; <em>erythema multiforme</em>).</p><p>These are very rare in people taking Augmentin. Signs include:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes, and genitals (<em>Stevens-Johnson syndrome</em>), and a more severe form, causing blisters and peeling skin on much of the body surface (<em>toxic epidermal necrolysis</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a widespread, red, skin rash with small blisters containing pus</p><p>(<em>exanthemous pustulosis</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a red, itchy, scaly rash with blisters and bumps under the skin (<em>bullous exfoliative dermatitis</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flu-like symptoms with a rash, fever, swollen glands, and abnormal blood test results (including white blood cells (<em>eosinophilia</em>) and liver enzymes) (<em>Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS))</em>.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a red rash commonly seen on both sides of buttocks, upper inner thighs, armpits, neck (Symmetrical Drug-related Intertriginous and Flexural Exanthema (SDRIFE)).</p><p>&nbsp;</p><p><strong>&egrave;</strong><strong>Get medical help immediately </strong>if you get any of these symptoms<strong>. Stop taking Augmentin.</strong></p><p><strong>Serious liver problems </strong></p><p>On rare occasions, medicines like Augmentin can cause liver problems, causing yellowing of the skin and/or whites of the eyes.</p><p>&egrave;Tell your doctor as soon as possible if you get any of these symptoms.</p><p>Severe diarrhoea (Pseudomembranous colitis)<!--[if supportFields]><span style='mso-bidi-font-size:
12.0pt;line-height:107%;mso-ascii-font-family:Arial;mso-ascii-theme-font:minor-bidi;
mso-hansi-font-family:Arial;mso-hansi-theme-font:minor-bidi;mso-bidi-font-family:
Arial;mso-bidi-theme-font:minor-bidi;font-style:normal'><span style='mso-element:
field-begin'></span> DOCVARIABLE vault_nd_bdb09e91-0b6b-456e-a473-a51ef63cffc7
\* MERGEFORMAT <span style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='mso-bidi-font-size:12.0pt;line-height:107%;mso-ascii-font-family:Arial;
mso-ascii-theme-font:minor-bidi;mso-hansi-font-family:Arial;mso-hansi-theme-font:
minor-bidi;mso-bidi-font-family:Arial;mso-bidi-theme-font:minor-bidi;
font-style:normal'><span style='mso-element:field-end'></span></span><![endif]--></p><p>On rare occasions, medicines like Augmentin can cause inflammation of the colon (large intestine), causing diarrhoea, usually with blood and mucus, stomach pain and fever.</p><p>&egrave;Tell your doctor as soon as possible if you get any of these symptoms.</p><p><strong>Very common side effects&nbsp; </strong></p><p>These may affect <strong>more than 1 in 10</strong> people:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diarrhoea (in adults).</p><p><strong>Common side effects&nbsp; </strong></p><p>These may affect <strong>up to 1 in 10 </strong>people:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thrush (fungal infection caused by <em>Candida</em> in the vagina, mouth or skin folds)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sick (<em>nausea)</em></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vomiting</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diarrhoea (in children).</p><p><strong>Uncommon side effects&nbsp; </strong></p><p>These may affect <strong>up to 1 in 100</strong> people:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; indigestion</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin rash</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itching</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itchy, bumpy rash (<em>hives</em>)</p><p>Uncommon side effects that may show up in blood tests are:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increase in some substances (enzymes) produced by the liver</p><p><strong>Rare side effects&nbsp; </strong></p><p>These may affect <strong>up to 1 in 1,000</strong> people:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin rash, which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge &ndash; <em>erythema multiform</em>e) (See <em>&lsquo;serious skin reactions&rsquo;</em> earlier in Section 4)</p><p>Rare side effects that may show up in blood tests are:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in the number of white blood cells (<em>leucopenia</em>, including <em>neutropenia)</em></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in the number of cells that help blood to clot</p><p>(<em>thrombocytopenia</em>)</p><p><strong>Very rare side effects&nbsp; </strong></p><p>These may affect <strong>up to 1 in 10,000</strong> people:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe allergic reactions (<em>See also <strong>&lsquo;severe allergic reactions&rsquo;</strong> earlier in Section 4</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; serious skin reactions (<em>See also <strong>&lsquo;serious skin reactions&rsquo;</strong> earlier in Section 4</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the liver (<em>hepatitis</em>) (<em>See also <strong>&lsquo;serious liver problems&rsquo;</strong> earlier in Section 4</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; yellowing of the whites of the eyes or skin (<em>jaundice</em>) (<em>See also <strong>&lsquo;serious liver problems&rsquo;</strong> earlier in Section 4</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the large intestines (<em>See also <strong>&lsquo;severe diarrhoea&rsquo;</strong> earlier in Section 4</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the kidney (<em>nephritis</em>)</p><p>an increase in the time blood takes to clot</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; being unusually active (<em>hyperactivity</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fits (<em>seizures</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; black tongue which looks hairy<strong><em> </em></strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the protective membrane surrounding the brain (aseptic meningitis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash with blisters arranged in a circle with central crusting or like a string of pearls (linear IgA disease).</p><p>Very rare side effects that may show up in blood or urine tests are:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe decrease in the number of white blood cells (<em>agranulocytosis</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; red blood cells destroyed too quickly (<em>haemolytic anaemia</em>)</p><p>&bull; &nbsp; crystals in urine</p><p>&egrave; <strong>Tell your doctor or pharmacist</strong> if any of the side effects listed becomes <strong>severe or troublesome</strong>, or if you notice any side effects not listed in this leaflet <strong> </strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Keep out of the sight and reach of children</strong>.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not take Augmentin after the expiry date shown on the pack.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store at below 25&deg;C, in a dry place, in the original packaging to protect from moisture.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contains desiccant sachet, do not remove or eat.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not store the open blister pouch above 25&deg;C. Throw away any unused tablets 30 days after first opening.</p><p>Don&rsquo;t dispose of medicines in wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help to protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Augmentin contains&nbsp; </strong></p><p>The active substances are amoxicillin and clavulanic acid.</p><p>Augmentin tablets come in different strengths.</p><p>Each tablet contains either:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; amoxicillin trihydrate equivalent to 500 mg amoxicillin and potassium clavulanate equivalent to 125 mg clavulanic acid</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; amoxicillin trihydrate equivalent to 875 mg amoxicillin and potassium clavulanate equivalent to 125 mg clavulanic acid</p><p>&nbsp;</p><p>The other ingredients are:</p><p>AUGMENTIN contains magnesium stearate, sodium starch glycollate, colloidal silicon dioxide, microcrystalline cellulose, titanium dioxide (E171), hydroxypropyl methylcellulose, polyethylene glycol and dimethicone (silicone oil).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                AUGMENTIN 625 mg tablets: A white to off-white oval- shaped film- coated debossed tablet, debossed with ‘AC’ and a score line on one side and plain on the other side. Blister packs of 20 in a carton. 
 
AUGMENTIN 1 g tablets: A white to off-white capsule-shaped film-coated tablet, debossed with ‘AC’ on both sides and a score line on one side. Blister packs of 14 in a carton. 

Not all presentations are available in every country. 
 
AUGMENTIN is a trademark owned by or licensed to the GSK group of companies.  
© 2024 GSK group of companies, all rights reserved. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufactured by:</strong></p><p>SmithKline Beecham plc.* Worthing, UK.</p><p><strong>&nbsp;</strong></p><p><strong>Packed by &amp; MAH: </strong>&nbsp;</p><p>Glaxo Saudi Arabia Ltd.* Jeddah, Kingdom of Saudi Arabia.</p><p>*member of GSK group of companies.</p><p>&nbsp;</p><p><strong>For any information about this medicinal product, please contact: </strong></p><p><strong>GSK - Head Office, Jeddah </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: gcc.medinfo@gsk.com</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[if gte vml 1]><v:roundrect
 id="Rectangle_x003a__x0020_Rounded_x0020_Corners_x0020_1" o:spid="_x0000_s1026"
 style='position:absolute;left:0;text-align:left;margin-left:-6.9pt;
 margin-top:28.35pt;width:462.5pt;height:234pt;text-indent:0;z-index:251662336;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:middle' arcsize="10923f" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" fillcolor="white [3201]" strokecolor="black [3213]" strokeweight="1.5pt">
 <v:stroke joinstyle="miter"/>
 <v:textbox>
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
    12.0pt;margin-left:15.25pt;line-height:normal'><b><span style='mso-bidi-font-size:
    12.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-theme-font:major-bidi'>To report any side effect(s):</span></b><span
    style='mso-bidi-font-size:12.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
    <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
    0in;margin-left:15.25pt;line-height:normal'><b><i><span style='mso-bidi-font-size:
    12.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-theme-font:major-bidi'>Kingdom of Saudi Arabia</span></i></b><span
    style='mso-bidi-font-size:12.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
    <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
    0in;margin-left:15.25pt;line-height:normal'><b><span style='mso-bidi-font-size:
    12.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-theme-font:major-bidi'>-National Pharmacovigilance centre (NPC)</span></b><span
    style='mso-bidi-font-size:12.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
    <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
    0in;margin-left:.5in;text-indent:-.25in;line-height:115%;mso-list:l1 level2 lfo2;
    tab-stops:list 1.0in;vertical-align:middle'><![if !supportLists]><span
    style='font-size:10.0pt;mso-bidi-font-size:12.0pt;line-height:115%;
    font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><span style='font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-fareast-font-family:
    "Times New Roman";mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>Reporting
    Hotline: 19999</span><span style='mso-bidi-font-size:12.0pt;line-height:
    115%;font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
    <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
    0in;margin-left:.5in;text-indent:-.25in;line-height:115%;mso-list:l1 level2 lfo2;
    tab-stops:list 1.0in;vertical-align:middle'><![if !supportLists]><span
    style='font-size:10.0pt;mso-bidi-font-size:11.0pt;line-height:115%;
    font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><span style='font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-fareast-font-family:
    "Times New Roman";mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>E-mail:
    </span><a href="mailto:npc.drug@sfda.gov.sa"><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
    text-decoration:none;text-underline:none'>npc.drug@sfda.gov.sa </span></a><span
    style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
    <p class=MsoNormal style='margin-left:.5in;text-indent:-.25in;line-height:
    115%;mso-list:l1 level2 lfo2;tab-stops:list 1.0in;vertical-align:middle'><![if !supportLists]><span
    style='font-size:10.0pt;mso-bidi-font-size:11.0pt;line-height:115%;
    font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><span style='font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-fareast-font-family:
    "Times New Roman";mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>Website:
    </span><a href="https://ade.sfda.gov.sa/"><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
    text-decoration:none;text-underline:none'>https://ade.sfda.gov.sa</span></a><span
    style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
    <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
    0in;margin-left:15.25pt;line-height:normal'><b><span style='mso-bidi-font-size:
    12.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-theme-font:major-bidi'>-GSK - Head Office, Jeddah</span></b><span
    style='mso-bidi-font-size:12.0pt;font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
    <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
    0in;margin-left:.5in;text-indent:-.25in;line-height:115%;mso-list:l1 level2 lfo2;
    tab-stops:list 1.0in;vertical-align:middle'><![if !supportLists]><span
    style='font-size:10.0pt;mso-bidi-font-size:12.0pt;line-height:115%;
    font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><span style='font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-fareast-font-family:
    "Times New Roman";mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>Tel:&nbsp;
    +966-12-6536666</span><span style='mso-bidi-font-size:12.0pt;line-height:
    115%;font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
    <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
    0in;margin-left:.5in;text-indent:-.25in;line-height:115%;mso-list:l1 level2 lfo2;
    tab-stops:list 1.0in;vertical-align:middle'><![if !supportLists]><span
    style='font-size:10.0pt;mso-bidi-font-size:12.0pt;line-height:115%;
    font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><span style='font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-fareast-font-family:
    "Times New Roman";mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>Mobile:
    +966-56-904-9882</span><span style='mso-bidi-font-size:12.0pt;line-height:
    115%;font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
    <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
    0in;margin-left:.5in;text-indent:-.25in;line-height:115%;mso-list:l1 level2 lfo2;
    tab-stops:list 1.0in;vertical-align:middle'><![if !supportLists]><span
    style='font-size:10.0pt;mso-bidi-font-size:11.0pt;line-height:115%;
    font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><span style='font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-fareast-font-family:
    "Times New Roman";mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>Email:
    </span><a href="mailto:saudi.safety@gsk.com"><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
    text-decoration:none;text-underline:none'>saudi.safety@gsk.com</span></a><span
    style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
    <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
    0in;margin-left:.5in;text-indent:-.25in;line-height:115%;mso-list:l1 level2 lfo2;
    tab-stops:list 1.0in;vertical-align:middle'><![if !supportLists]><span
    style='font-size:10.0pt;mso-bidi-font-size:11.0pt;line-height:115%;
    font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><a
    href="https://gskpro.com/en-sa/"><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
    text-decoration:none;text-underline:none'>W</span></a><span
    style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-theme-font:major-bidi'>ebsite: </span><a
    href="https://gskpro.com/en-sa/"><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
    text-decoration:none;text-underline:none'>https://gskpro.com/en-sa/ </span></a><span
    style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
    <p class=MsoListParagraph style='text-indent:-.25in;line-height:115%;
    mso-list:l1 level1 lfo2;tab-stops:list .5in'><![if !supportLists]><span
    style='font-size:10.0pt;mso-bidi-font-size:11.0pt;line-height:115%;
    font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><span style='font-family:
    "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-fareast-font-family:
    "Times New Roman";mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>P.O.
    Box 55850, Jeddah 21544, </span><span style='font-size:11.0pt;line-height:
    115%;font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
    mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>Kingdom of
    Saudi Arabia</span><span style='font-family:"Times New Roman",serif;
    mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
    major-bidi'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap type="square"/>
</v:roundrect><![endif]--><img width="622" height="317" alt="Rectangle: Rounded Corners: To report any side effect(s):
Kingdom of Saudi Arabia
-National Pharmacovigilance centre (NPC)
•	Reporting Hotline: 19999
•	E-mail: npc.drug@sfda.gov.sa 
•	Website: https://ade.sfda.gov.sa
-GSK - Head Office, Jeddah
•	Tel:  +966-12-6536666
•	Mobile: +966-56-904-9882
•	Email: saudi.safety@gsk.com
•	Website: https://gskpro.com/en-sa/ 
•	P.O. Box 55850, Jeddah 21544, Kingdom of Saudi Arabia
" src="file:///C:/Users/aa630244/AppData/Local/Temp/msohtmlclip1/01/clip_image001.gif" />P.O Box 55850, Jeddah 21544, Kingdom of Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Version number: GDS29 
Date of issue:  07 September 2023



            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">أوجمنتين هو مضاد حيوي يتناوله البالغون والأطفال لعلاج الالتهابات في الأجزاء المختلفة من الجسم التي تسببها أنواع معينة من البكتيريا.&nbsp;</p><p dir="RTL">يحتوي أوجمنتين على مادتين&nbsp; مختلفتين، هما: الأموكسيسيلين وحمض الكلاڤيولانيك. الأموكسيسيلين هو مضاد حيوي يحتوي على بنسلين. يمكن أحيانا مقاومة الأموكسيسيلين)جعله غير فعال)، لذا تساعد المادة الفعالة الأخرى -حمض&nbsp; الكلاڤيولانيك-&nbsp; على منع&nbsp; بعض&nbsp; البكتريا من أن&nbsp; تصبح مقاومة للأموكسيسيلين.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا تتناول أوجمنتين إذا:&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من حساسية )حساسية&nbsp; شديدة) تجاه الأموكسيسيلين، أو حمض الكلاڤيولانيك، أو المضادات الحيوية الأخرى القائمة على البنسلين، أو المضادات الحيوية المماثلة التي تسمى السيفالوسبورينات.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من مشاكل بالكبد أو اليرقان )اصفرار الجلد و/ أو بياض العين) عند تناول المضاد الحيوي.</p><p dir="RTL">&ccedil; إذا انطبق عليك أي مما سبق، تحدث إلى طبيبك قبل تناول أوجمنتين.</p><p dir="RTL">الاحتياطات الخاصة التي يجب مراعاتها عند تناول أوجمنتين&nbsp;</p><p dir="RTL">تحدث إلى طبيبك قبل تناول أوجمنتين إذا:&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعرضت من قبل لرد فعل تحسسي تجاه أي مضادات حيوية أو أدوية أخرى، وقد يشمل ذلك الطفح الجلدي أو تورم الوجه أو الرقبة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك حمى غُدِّيّة )كثرة الوحيدات العدوائية).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تتناول الأدوية - مثل وارفارين- التي تستخدم لمنع تجلط الدم.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من مشاكل بالكبد.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من مرض بالكلى.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت لا تتبول بانتظام أو لا تستطيع الشرب بكثرة.&nbsp;</p><p dir="RTL">&ccedil; <strong>تحدث إلى طبيبك</strong> إذا انطبق عليك أي مما سبق. سيقرر طبيبك ما إذا كان أوجمنتين مناسبا لك وقد يحتاج إلى تعديل جرعتك أو إعطائك دواء مختلفا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>انتبه إلى الأعراض المهمة&nbsp; </strong></p><p dir="RTL">يمكن أن يجعل أوجمنتين بعض الحالات الحالية أسوأ أو يسبب آثارا&nbsp; جانبية خطيرة، مثل: <strong>ردود الفعل&nbsp; التحسسية الشديدة، أو التفاعلات الجلدية الخطيرة، ألم في الصدر، </strong><strong>القيء المتكرر خلال ساعة إلى 4 ساعات من تلقي دواء أوجمنتين</strong><strong> أو أمراض الكبد الخطيرة، أو الإسهال الشديد، أو التهاب&nbsp; الأمعاء الغليظة</strong> <strong>)</strong><strong>التهاب القولون الغشائي الكاذب)</strong>. يجب&nbsp; أن تنتبه إلى بعض الأعراض أثناء تناولك أوجمنتين للمساعدة في تقليل مخاطر حدوث أي مشكلات . انظر &quot;انتبه إلى الأعرا ض المهمة&quot; في <strong>القسم 4</strong>.&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أثناء تناول أوجمنتين&nbsp; </strong></p><p dir="RTL"><strong>تفاعلات أوجمنتين مع الأدوية الأخرى&nbsp; </strong></p><p dir="RTL"><strong>يرجى إبلاغ طبيبك أو الصيدلي إذا كنت تتناول</strong> أو قد تناولت مؤخرا&nbsp; <strong>أية أدوية أخرى</strong> أو إذا بدأت في تناول أدوية جديدة، ويشمل ذلك تلك التي حصلت عليها دون وصفة طبية.&nbsp;</p><p dir="RTL">قد تؤثر بعض الأدوية على طريقة عمل أوجمنتين أو تزيد من احتمالية الإصابة بآثار جانبية. يمكن أن يؤثر أوجمنتين أيضًا على كيفية عمل بعض الأدوية الأخرى. ويشمل ذلك ما يلي :</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>البروبينسيد</strong> و<strong>الألوبيورينول</strong> )يستخدمان <strong>لعلاج النقرس</strong>).&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>مضادات التخثر</strong> ) تستخدم <strong>لمنع تجلط الدم</strong>) مثل وارفارين وأسينوكومارول.&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>ميكوفينولات موفيتيل</strong> )يستخدم <strong>لمنع رفض الأعضاء المزروعة)</strong>.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ميثوتريكسات )يستخدم لعلاج حالات مثل السرطان والصدفية الشديدة).</p><p dir="RTL">&ccedil; يرجى إبلاغ طبيبك أو الصيدلي إذا كنت تتناول أي مما سبق.&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يقلل أوجمنتين من مدى فاعلية <strong>حبوب منع الحمل</strong>. إذا كنتِّ&nbsp; تستخدمين حبوب منع الحمل أثناء تناولك أوجمنتين ، فيجب عليك أيضا&nbsp; استخدام <strong>وسيلة عازلة لمنع الحمل</strong> ) مثل الواقي الذكري). اسألي طبيبك للحصول على المشورة.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية&nbsp; </strong></p><p dir="RTL">إذا كنتِّ&nbsp; <strong>حاملاً، تظنين&nbsp; أنك حاملا ً</strong> أو <strong>تخططين لإنجاب طفل</strong>، <strong>فلا&nbsp; تأخذي أوجمنتين </strong>&nbsp;دون مراجعة طبيبك. سينظر <strong>طبيبك</strong> في الفائدة&nbsp; التي تعود&nbsp; عليكِّ&nbsp; والمخاطر التي يتعرض لها&nbsp; طفلك جراء تناول أوجمنتين أثناء الحمل.</p><p dir="RTL">يمكنك عادة الإرضاع طبيعيا أثناء تناولك أوجمنتين. إذا كنتِّ&nbsp; ترضعين طفلك طبيعيا أو تفكرين في الرضاعة الطبيعية، <strong>فاستشيري طبيبك قبل تناول أوجمنتين. </strong>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>احرص دائماً على تناول أوجمنتين تماما ً كما أخبرك طبيبك أو الصيدلي.</strong> إذا لم تكن متأكدا من كيفية التناول، يرجى مراجعة طبيبك أو الصيدلي.&nbsp;</p><p dir="RTL"><strong>ما هي الكمية التي يجب تناولها&nbsp; </strong></p><p dir="RTL">يقرر طبيبك الجرعة المناسبة لك</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>مرضى الكلى أو الكبد&nbsp; </strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل بالكلى، فقد يعطيك طبيبك تركيز مختلف أو دواء مختلف.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل بالكبد، يلزم إجراء المزيد من تحاليل الدم لمعرفة حالة الكبد.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>كيفية التناول&nbsp; </strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تناول أوجمنتين في بداية الوجبة أو قبلها بقليل .</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ابتلع القرص بالكامل مع كوب من الماء.</p><p dir="RTL">لا تتناول أوجمنتين لأكثر من 14 يوما. إذا كنت لا تزال تشعر بأنك لست على ما يرام، يجب عليك <strong>رؤية طبيبك</strong> مرة أخرى.&nbsp;</p><p dir="RTL"><strong>في حال نسيان تناول أوجمنتين&nbsp; </strong></p><p dir="RTL"><strong>لا تتناول جرعة مضاعفة لتعويض الجرعة التي نسيتها،</strong> فقط تناولها بمجرد تذكرك.&nbsp;</p><p dir="RTL"><strong>إذا لم تكن متأكدا ًمما يجب عليك فعله</strong>، فاسأل طبيبك أو الصيدلي.</p><p dir="RTL"><strong>في حال تناول كمية أكثر مما يجب من أوجمنتين&nbsp; </strong></p><p dir="RTL">إذا تناولت كمية أكثر مما يجب من أوجمنتين عن طريق الخطأ، فمن غير المرجح حدوث أي مشاكل خطيرة. الآثار الجانبية الأكثر شيوعا لتناول كمية أكثر مما يجب من أوجمنتين هي الغثيان والقيء والإسهال. إذا كنت قلقا&nbsp; أو تشعر بتوعك:</p><p dir="RTL">&ccedil; اسأل طبيبك أو الصيدلي للحصول على المشورة.</p><p dir="RTL"><strong>لا تتوقف عن تناول أوجمنتين دون استشارة الطبيب&nbsp; </strong></p><p dir="RTL"><strong>من المهم أن تأخذ دورة كاملة من أوجمنتين</strong>. لا تتوقف عن تناول الدواء إلا إذا نصحك طبيبك بذلك، حتى لو كنت تشعر بتحسن. إذا لم تكمل دورة العلاج بالكامل، فقد تعود العدوى مرة أخرى.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">قد يسبب هذا الدواء آثارا جانبية -مثل جميع الأدوية- ومع ذلك لا يشعر بها جميع الأشخاص.&nbsp;</p><p dir="RTL"><strong>انتبه إلى الأعراض المهمة&nbsp; </strong></p><p dir="RTL"><strong>ردود الفعل التحسسية الشديدة&nbsp; </strong></p><p dir="RTL">هذه نادرة جدا لدى الأشخاص الذين يتناولون أوجمنتين، وتشمل المؤشرات:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي المثير للحكة) الشرى)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأوعية الدموية )الالتهاب الوعائي) الذي يمكن رؤيته على شكل بقع حمراء أو أرجوانية بارزة على الجلد، ولكن قد يؤثر على أجزاء أخرى من الجسم.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحمى وآلام المفاصل وتورم الغدد في الرقبة أو الإبط أو الفخذ.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انتفاخ أحيانا في الوجه أو الفم )الوذمة الوعائية)، مما قد يسبب صعوبة في البلع أو التنفس</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الهبوط&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في الصدر يمكن أن يكون علامة على رد فعل تحسسي خطير محتمل يسمى متلازمة كونس</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;القيء المتكرر)خلال ساعة إلى 4 ساعات من تلقي الدواء <strong>أوجمنتين</strong>)، آلام في المعدة، نعاس غير طبيعي، إسهال، وانخفاض ضغط الدم، والتي يمكن أن تكون علامة على رد فعل تحسسي خطير يسمى متلازمة التهاب الأمعاء والقولون الناجم عن الأدوية. &nbsp;</p><p dir="RTL">&ccedil; <strong>احصل على المساعدة الطبية فور اً</strong> إذا ظهرت عليك أي من هذه الأعراض. <strong>توقف عن تناول أوجمنتين.</strong></p><p dir="RTL"><strong>التفاعلات الجلدية الخطيرة&nbsp; </strong></p><p dir="RTL">هذه نادرة لدى الأشخاص الذين يتناولون أوجمنتين، وتشمل المؤشرات:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي الذي قد يتحول إلى قرح، ويبدو كبقع صغيرة )بقع مركزية داكنة محاطة بمنطقة شاحبة مع حلقة داكنة حول الحافة</p><p dir="RTL">- حمامي متعددة الأشكال)&nbsp;</p><p dir="RTL">هذه نادرة جدا&nbsp; لدى الأشخاص الذين يتناولون أوجمنتين، وتشمل المؤشرات:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي منتشر مع ظهور بثور وتقشر الجلد، خاصة حول الفم والأنف والعينين والأعضاء التناسلية) &nbsp;متلازمة ستيفنز- جونسون)، والشكل الأكثر حدة يسبب بثورا وتقشرا للجلد على معظم سطح الجسم) &nbsp;انحلال البشرة السمي)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي أحمر منتشرمع ظهور بثور صغيرة بها صديد) البثور ذو الطفح الجلدي الظاهر)&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي أحمر متقشر مثير للحكة مع ظهور رضوض تحت الجلد وبثور)التهاب الجلد التقشري الفقاعي)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أعراض شبيهة بالإنفلونزا مع الطفح الجلدي، والحمى، وتضخم الغدد، ونتائج غير طبيعية لتحاليل الدم )بما في ذلك خلايا الدم البيضاء) فرط الحمضات) وإنزيمات الكبد) ) تفاعل الدواء مع فرط الحمضات والأعراض الجهازية).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يظهر عادة طفح جلدي أحمر على الأرداف كلتيهما، والجزء العلوي الداخلى من الفخذين، وتحت الإبطين، والرقبة( الطفح الجلدي وبين الثنايا المتماثل والمتعلق بالدواء(SDRIFE))</p><p dir="RTL">&ccedil;<strong>احصل على المساعدة الطبية فور اً</strong> إذا ظهرت عليك أي من هذه الأعراض. <strong>توقف عن تناول أوجمنتين. </strong></p><p dir="RTL"><strong>مشاكل خطيرة بالكبد&nbsp; </strong></p><p dir="RTL">في حالات نادرة، يمكن أن تسبب الأدوية مثل <strong>أوجمنتين</strong> مشاكل بالكبد، مما يؤدي إلى اصفرار الجلد و/ أو بياض العينين.&nbsp;</p><p dir="RTL">&ccedil;اتصل بطبيبك في أقرب وقت ممكن إذا ظهرت عليك أي من هذه الأعراض.&nbsp;</p><p dir="RTL"><strong>الإسهال الشديد</strong><strong>) </strong><strong>التهاب القولون الغشائي الكاذب</strong><strong>)&nbsp; </strong></p><p dir="RTL">في حالات نادرة، يمكن أن تسبب الأدوية مثل <strong>أوجمنتين</strong> التهاب القولون )الأمعاء الغليظة) الذي يسبب الإسهال ويكون عادة مصحوب بالدم&nbsp; والمخاط وآلام في المعدة والحمى.</p><p dir="RTL">&ccedil;اتصل بطبيبك في أقرب وقت ممكن إذا ظهرت عليك أي من هذه الأعراض.&nbsp;</p><p>&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية الشائعة جدًا&nbsp; </strong></p><p dir="RTL">قد تظهرهذه الأعراض لدى<strong> أكثر من </strong>شخص واحد من بين كل <strong>10</strong> أشخاص:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإسهال )عند البالغين.)</p><p dir="RTL">&nbsp;<strong>الآثار الجانبية الشائعة&nbsp; </strong></p><p dir="RTL">قد تظهر هذه الأعراض لدى شخص<strong> واحد</strong> من بين كل <strong>10</strong> أشخاص:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; القلاع )عدوى فطرية تسببها المبيضة وتصيب المهبل أو الفم أو ثنايا الجلد)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالغثيان&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; القيء</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإسهال )عند الأطفال)</p><p dir="RTL">&nbsp;<strong>الآثار الجانبية غير الشائعة&nbsp; </strong></p><p dir="RTL">قد تظهر هذه الأعراض لدى شخص<strong> واحد</strong> من بين كل <strong>100</strong> شخص:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الدوخة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصداع</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عسر الهضم</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحكة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي البارز المثير للحكة )الشرى )</p><p dir="RTL">الآثار الجانبية غير الشائعة التي قد تظهر في تحاليل الدم :</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في بعض المواد )الإنزيمات) التي ينتجها الكبد</p><p dir="RTL">&nbsp; <strong>الآثار الجانبية النادرة&nbsp; </strong></p><p dir="RTL">قد تظهر هذه الأعراض لدى شخص<strong> واحد</strong> من بين كل <strong>1000</strong> شخص:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي الذي قد يتحول إلى قرح، ويبدو كبقع صغيرة )بقع مركزية داكنة محاطة بمنطقة شاحبة مع حلقات داكنة حول الحافة- حمامي متعددة الأشكال) )انظر&quot; التفاعلات الجلدية الخطيرة&quot; سابقا&nbsp; في القسم 4)</p><p dir="RTL">&nbsp;</p><p dir="RTL">الآثار الجانبية النادرة التي قد تظهر في تحاليل الدم :</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد خلايا الدم البيضاء) &nbsp;قلة الكريات البيضاء، بما في ذلك قلة العدلات)&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد الخلايا التي تساعد على تجلط الدم) قلة الصفيحات)</p><p dir="RTL">&nbsp;<strong>الآثار الجانبية النادرة جدًا&nbsp; </strong></p><p dir="RTL">قد تظهر هذه الأعراض لدى شخص<strong> واحد</strong> من بين كل<strong> 10,000 </strong>شخص:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ردود الفعل التحسسية الشديدة )انظر أيضا &quot; <strong>ردود الفعل التحسسية الشديدة</strong>&quot; سابقا&nbsp; في القسم 4)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التفاعلات الجلدية الخطيرة) انظر أيضا <strong>&quot;التفاعلات الجلدية الخطيرة</strong>&quot; سابقا&nbsp; في القسم 4)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكبد) التهاب الكبد الوبائي)) انظر أيضا&nbsp; &quot;<strong>المشاكل الخطيرة بالكبد</strong>&quot; سابقا&nbsp; في القسم 4)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اصفرار بياض العينين أو الجلد)اليرقان) )انظر أيضا&nbsp; &quot;<strong>المشاكل الخطيرة بالكبد</strong>&quot; سابقا&nbsp; في القسم 4)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأمعاء الغليظة ) انظرأيضا &quot;<strong>الإسهال الحاد</strong>&quot; سابقا&nbsp; في القسم 4)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكلية) الالتهاب الكلوي)&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة الوقت الذي يستغرقه الدم للتجلط</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النشاط غير المعتاد) فرط النشاط)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النوبات) التشنجات)&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اللسان الأسود الذي يبدو مشعرا &nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الغشاء الواقي المحيط بالدماغ) التهاب السحايا العقيم)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;طفح جلدي مع ظهور بثور مرتبة بشكل دائري مع تقشر مركزي أو مثل سلسلة من اللآلئ )داء الجلوبولين المناعيأ الخطي).&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">الآثار الجانبية النادرة جدا&nbsp; التي قد تظهر في تحاليل الدم أو البول :</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض حاد في عدد خلايا الدم البيضاء) &nbsp;ندرة المحببات)&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تدمير خلايا الدم الحمراء بسرعة كبيرة) &nbsp;فقر الدم الانحلالي)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بلورات في البول</p><p dir="RTL">&ccedil; <strong>تحدث إلى&nbsp; طبيبك أو الصيدلي</strong> إذا أصبحت أي من الآثار الجانبية المذكورة <strong>شديدة أو مزعجة</strong>، أو إذا لاحظت أي آثار جانبية غير&nbsp; مدرجة في هذه النشرة الطبية.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>يحفظ هذا الدواء بعيد اً عن رؤية ومتناول الأطفال.&nbsp; </strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتناول أوجمنتين بعد تاريخ انتهاء الصلاحية المدون على العبوة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحُفظ هذا الدواء في درجة حرارة أقل من 25 &deg;C، في العلبة الأصلية في مكان جاف لحمايته من الرطوبة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تحتوي على كيس مجفف، لا تزيله أو تتناوله</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تخزن كيس شريط تغليف الأدوية المفتوح في درجة حرارة أعلى من 25 &deg;C. تخلص من أي أقراص غير مستخدمة بعد</p><p dir="RTL">30 يوما من فتحها لأول مرة.&nbsp;</p><p dir="RTL">لا تتخلص من الأدوية عن طريق إلقائها في مياه الصرف أو مع المخلفات المنزلية. استشر الصيدلي الخا ص بك عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. ستساعد هذه الإجراءات على حماية البيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>محتويات أوجمنتين&nbsp; </strong></p><p dir="RTL">الأموكسيسيلين وحمض الكلاڤيولانيك هما المواد الفعالة في هذا الدواء.</p><p dir="RTL">تأتي أقراص أوجمنتين بتركيزات&nbsp; مختلفة.</p><p dir="RTL">يحتوي كل قرص على أي مما يلي:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&bull; أموكسيسيلين ثلاثي الهيدرات بما يعادل&nbsp; 500&nbsp; ملجم من الأموكسيسيلين، وبوتاسيوم كلافولانات بما يعادل&nbsp; 125&nbsp; ملجم من حمض الكلاڤيولانيك</p><p dir="RTL">&nbsp; &bull; أموكسيسيلين ثلاثي الهيدرات بما يعادل&nbsp; 875&nbsp; ملجم&nbsp; من الأموكسيسيلين، وبوتاسيوم كلافولانات بما يعادل&nbsp; 125&nbsp; ملجم من حمض الكلاڤيولانيك&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">المكونات الأخرى هي:&nbsp;</p><p dir="RTL">يحتوي كل قرص على سترات الماغنيسيوم، جلايكولات نشا الصوديوم، ثاني أوكسيد السيليكون الغروي ،سليولوز دقيق التبلور، ثاني أكسيد التيتانيوم) 171E)، هيدروكسي پروپيل ميثيل سليولوز، پولي إيثيلين جلايكول ودايميثيكون) زيت السيلكون).</p><p dir="RTL">&nbsp;</p><p>&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيف يبدو</strong> <strong>أوجمنتين وما هي محتويات العبوة </strong></p><p dir="RTL">أقراص أوجمنتين 625 ملجم: أقراص بيضاء إلى شبه بيضاء بيضاوية الشكل مكسوة بكسوة غشائية منقوش على أحد وجهيها&quot; AC&quot; مع خط منصف والوجه الآخر أملس. عبوات فقاعية سعة 20 قرص في العبوة .</p><p dir="RTL">أقراص أوجمنتين 1 جم: أقراص مكسوة بكسوة غشائية، بيضاء إلى شبه بيضاء على شكل كبسول منقوش على كلا وجهيها &quot;AC&quot; مع خط منصف على أحد وجهيها. عبوات فقاعية سعة 14 قرص في العبوة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لاتتوافر جميع أشكال العبوات في كل بلد.</p><p dir="RTL">&nbsp;</p><p dir="RTL">العلامات التجارية مملوكة أو مرخصة لمجموعة شركات جلاكسو سميث كلاين&nbsp;</p><p dir="RTL">&copy; 2024 مجموعة شركات جلاكسو سميث كلاين. جميع الحقوق محفوظة<strong>. </strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>تصنيع : </strong></p><p dir="RTL">سميث كلاين بيتشام پي إل سي.* ورثينج، المملكة المتحدة.&nbsp;</p><p dir="RTL"><strong>تعبئة وتسويق : </strong></p><p dir="RTL">جلاكسو العربية السعودية المحدودة* جدة، المملكة العربية السعودية.</p><p dir="RTL">*عضو في مجموعة شركات جلاكسو سميث كلاين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للاستفسار عن أية معلومات عن هذا المستحضر الدوائي، يرجى الاتصال بالأرقام التالية:&nbsp; </strong></p><p dir="RTL">جلاكسو سميث كلاين، المكتب الرئيسي، جدة.</p><ul><li><ul><li dir="RTL">هاتف: 6536666 (12) 966 +</li><li dir="RTL">جوال:9882-904-56 966 +</li><li dir="RTL">البريد الإلكتروني: gcc.medinfo@gsk.com</li><li dir="RTL">الموقع الإلكتروني: https://gskpro.com/en-sa/</li><li dir="RTL">ص.ب. 55850، جدة 21544، المملكة العربية السعودية</li></ul></li></ul><p>&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><!--[if gte vml 1]><v:roundrect
 id="Rectangle_x003a__x0020_Rounded_x0020_Corners_x0020_4" o:spid="_x0000_s1028"
 style='position:absolute;left:0;text-align:left;margin-left:0;margin-top:-8.2pt;
 width:481.9pt;height:244pt;z-index:251663360;visibility:visible;
 mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;
 mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:center;
 mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
 mso-width-relative:page;mso-height-relative:page;v-text-anchor:top' arcsize="10923f"
 o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" strokeweight="2.5pt">
 <v:textbox inset=",0,,0">
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoNormal align=left dir=RTL style='margin-bottom:0in;text-align:
    right'><b><span lang=AR-SA style='font-size:14.0pt;line-height:107%;
    font-family:"Traditional Arabic",serif'>للإبلاغ عن أية آثار جانبية</span></b><b><span
    lang=AR-SA style='font-size:12.0pt;mso-ansi-font-size:11.0pt;line-height:
    107%;font-family:"Traditional Arabic",serif'>:</span></b><b><span dir=LTR
    style='mso-bidi-font-size:12.0pt;line-height:107%;font-family:"Traditional Arabic",serif'><o:p></o:p></span></b></p>
    <p class=MsoNormal align=left dir=RTL style='margin-bottom:0in;text-align:
    right'><b><i><span lang=AR-SA style='font-size:13.0pt;line-height:107%;
    font-family:"Traditional Arabic",serif'>المملكة العربية السعودية</span></i></b><b><i><span
    dir=LTR style='font-size:13.0pt;line-height:107%;font-family:"Traditional Arabic",serif'><o:p></o:p></span></i></b></p>
    <p class=MsoNormal align=left dir=RTL style='margin-bottom:0in;text-align:
    right;line-height:115%'><span dir=RTL></span><b><span lang=AR-SA
    style='font-family:"Traditional Arabic",serif'><span dir=RTL></span>- </span></b><b><span
    lang=AR-SA style='font-family:"Times New Roman",serif'>المركز الوطني للتيقظ
    والسلامة الدوائية )</span></b><b><span dir=LTR style='font-family:"Times New Roman",serif'>NPC</span></b><span
    dir=RTL></span><b><span lang=AR-SA style='font-family:"Times New Roman",serif'><span
    dir=RTL></span>)</span></b><b><span dir=LTR style='font-family:"Times New Roman",serif'><o:p></o:p></span></b></p>
    <p class=MsoListParagraph align=left dir=RTL style='margin-bottom:0in;
    text-align:right;text-indent:-.25in;line-height:115%;mso-list:l1 level1 lfo3'><![if !supportLists]><span
    style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol;color:windowtext'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-family:"Times New Roman",serif'>الاتصال
    بالرقم الموحد: 19999<span style='mso-spacerun:yes'>  </span><o:p></o:p></span></p>
    <p class=MsoListParagraph align=left dir=RTL style='margin-bottom:0in;
    text-align:right;text-indent:-.25in;line-height:115%;mso-list:l1 level1 lfo3'><![if !supportLists]><span
    style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol;color:windowtext'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-family:"Times New Roman",serif'>البريد
    الإلكتروني: </span><a href="mailto:npc.drug@sfda.gov.sa"><span dir=LTR
    style='font-family:"Times New Roman",serif;color:black;text-decoration:
    none;text-underline:none'>npc.drug@sfda.gov.sa</span></a><span dir=LTR
    style='font-family:"Times New Roman",serif'> <o:p></o:p></span></p>
    <p class=MsoListParagraph align=left dir=RTL style='margin-bottom:0in;
    text-align:right;text-indent:-.25in;line-height:115%;mso-list:l1 level1 lfo3'><![if !supportLists]><span
    style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol;color:windowtext'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-family:"Times New Roman",serif'>الموقع
    الإلكتروني:</span><span lang=AR-SA> </span><a
    href="https://ade.sfda.gov.sa/"><span dir=LTR style='font-family:"Times New Roman",serif;
    color:black;text-decoration:none;text-underline:none'>https://ade.sfda.gov.sa</span></a><span
    dir=LTR style='font-family:"Times New Roman",serif'><o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='margin-top:0in;margin-right:.25in;
    margin-bottom:0in;margin-left:0in'><span dir=LTR style='font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>
    <p class=MsoNormal align=left dir=RTL style='margin-bottom:0in;text-align:
    right;line-height:115%'><span dir=RTL></span><b><span lang=AR-SA
    style='font-family:"Times New Roman",serif'><span dir=RTL></span>- جلاكسو
    سميث كلاين – المكتب الرئيسي، جدة.</span></b><b><span dir=LTR
    style='font-family:"Times New Roman",serif'><o:p></o:p></span></b></p>
    <p class=MsoListParagraphCxSpFirst align=left dir=RTL style='margin-bottom:
    0in;mso-add-space:auto;text-align:right;text-indent:-.25in;line-height:
    115%;mso-list:l1 level1 lfo3;tab-stops:right 13.5pt'><![if !supportLists]><span
    style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol;color:windowtext'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-family:"Times New Roman",serif'>هاتف:
    6536666 -12- 966 +<o:p></o:p></span></p>
    <p class=MsoListParagraph align=left dir=RTL style='margin-bottom:0in;
    text-align:right;text-indent:-.25in;line-height:115%;mso-list:l1 level1 lfo3'><![if !supportLists]><span
    style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol;color:windowtext'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-family:"Times New Roman",serif'>جوال:
    9882-904-56 -966 +<o:p></o:p></span></p>
    <p class=MsoListParagraph align=left dir=RTL style='margin-bottom:0in;
    text-align:right;text-indent:-.25in;line-height:115%;mso-list:l1 level1 lfo3'><![if !supportLists]><span
    style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol;color:windowtext'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-family:"Times New Roman",serif'>البريد
    الإلكتروني : </span><span dir=LTR style='font-family:"Times New Roman",serif'>s</span><span
    dir=LTR><a href="mailto:audi.safety@gsk.com"><span style='font-family:"Times New Roman",serif;
    color:black;text-decoration:none;text-underline:none'>audi.safety@gsk.com</span></a></span><span
    lang=AR-SA style='font-family:"Times New Roman",serif'><o:p></o:p></span></p>
    <p class=MsoListParagraph align=left dir=RTL style='margin-bottom:0in;
    text-align:right;text-indent:-.25in;line-height:115%;mso-list:l1 level1 lfo3'><![if !supportLists]><span
    style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol;color:windowtext'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-family:"Times New Roman",serif'>الموقع
    الإلكتروني: </span><a href="https://gskpro.com/en-sa/"><span dir=LTR
    style='font-family:"Times New Roman",serif;color:black;text-decoration:
    none;text-underline:none'>https://gskpro.com/en-sa</span><span dir=RTL></span><span
    lang=AR-SA style='font-family:"Times New Roman",serif;color:black;
    text-decoration:none;text-underline:none'><span dir=RTL></span>/</span></a><span
    lang=AR-SA style='font-family:"Times New Roman",serif'><o:p></o:p></span></p>
    <p class=MsoListParagraph align=left dir=RTL style='margin-bottom:0in;
    text-align:right;text-indent:-.25in;line-height:115%;mso-list:l1 level1 lfo3'><![if !supportLists]><span
    style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol;color:windowtext'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-family:"Times New Roman",serif'>ص.ب
    55850، جدة 21544، المملكة العربية السعودية.</span><span dir=LTR
    style='font-family:"Times New Roman",serif'><o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='margin-bottom:0in;tab-stops:right 13.5pt'><span
    dir=LTR style='font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>
    <p class=MsoNormal dir=RTL style='margin-bottom:0in;tab-stops:right 13.5pt'><span
    lang=EN-US dir=LTR style='mso-bidi-font-size:12.0pt;line-height:107%;
    font-family:"Traditional Arabic",serif;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap anchorx="margin"/>
</v:roundrect><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><img width="649" height="332" alt="Rectangle: Rounded Corners: للإبلاغ عن أية آثار جانبية:
المملكة العربية السعودية
- المركز الوطني للتيقظ والسلامة الدوائية )NPC)
•	الاتصال بالرقم الموحد: 19999  
•	البريد الإلكتروني: npc.drug@sfda.gov.sa 
•	الموقع الإلكتروني: https://ade.sfda.gov.sa

- جلاكسو سميث كلاين – المكتب الرئيسي، جدة.
•	هاتف: 6536666 -12- 966 +
•	جوال: 9882-904-56 -966 +
•	البريد الإلكتروني : saudi.safety@gsk.com
•	الموقع الإلكتروني: https://gskpro.com/en-sa/
•	ص.ب 55850، جدة 21544، المملكة العربية السعودية.


" src="file:///C:/Users/aa630244/AppData/Local/Temp/msohtmlclip1/01/clip_image001.gif" /></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><!--[if gte vml 1]><v:group
 id="Group_x0020_38321" o:spid="_x0000_s1026" style='position:absolute;left:0;
 text-align:left;margin-left:0;margin-top:3.95pt;width:489.25pt;height:197.5pt;
 z-index:-251658240;mso-position-horizontal:center;
 mso-position-horizontal-relative:margin;mso-width-relative:margin;
 mso-height-relative:margin' coordsize="60293,30035" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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">
 <v:shape id="Shape_x0020_5599" o:spid="_x0000_s1027" style='position:absolute;
  width:60293;height:30035;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="6029326,3003550" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" path="m,500634c,224155,224130,,500634,l5528691,v276479,,500635,224155,500635,500634l6029326,2503043v,276479,-224156,500507,-500635,500507l500634,3003550c224130,3003550,,2779522,,2503043l,500634xe"
  filled="f" strokeweight="2.5pt">
  <v:path arrowok="t" textboxrect="0,0,6029326,3003550"/>
 </v:shape><w:wrap anchorx="margin"/>
</v:group><![endif]--><img width="656" height="267" src="file:///C:/Users/aa630244/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif" /></p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL">إن هذا الدوا ء</p><p dir="RTL">-&nbsp; الدواء مستحضر يؤثر على صحتك ، واستهلاكه خلافا للتعليمات يعرضك للخطر.&nbsp;</p><p dir="RTL">-&nbsp; اتبع بدقة وصفة الطبيب، وطريقة الاستعمال المنصوص عليها، وتعليمات الصيدلانى الذى صرفها لك.&nbsp;</p><p dir="RTL">-&nbsp; فالطبيب والصيدلانى هما الخبيران بالدواء ، وبنفعه وضرره.&nbsp;</p><p dir="RTL">-&nbsp; لا تقطع مدة العلاج المحددة لك من تلقاء نفسك.&nbsp;</p><p dir="RTL">-&nbsp; لا تكرر صرف الدواء بدون استشارة الطبيب .</p><p dir="RTL">-&nbsp; احتفظ بجميع الأدوية بعيدا عن متناول الأطفال&nbsp;&nbsp; .&nbsp; &nbsp;</p><p>مجلس وزراء الصحة العرب</p><p>اتحاد الصيادلة العرب</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            رقم الإصدار: GDS29 
تاريخ الإصدار: 07 September 2023  
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AUGMENTIN BID Tablet.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AUGMENTIN 625 mg tablets: Each tablet contains 500 mg amoxicillin (as amoxicillin trihydrate) and 125 mg clavulanic acid (as potassium clavulanate).

AUGMENTIN 1 g tablets: Each tablet contains 875 mg amoxicillin (as amoxicillin trihydrate) and 125 mg clavulanic acid (as potassium clavulanate).

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AUGMENTIN 625 mg tablets: A white to off-white oval- shaped film- coated tablet, debossed with ‘AC’ and a score line on one side and plain on the other side.

AUGMENTIN 1 g tablets: A white to off-white capsule-shaped film-coated tablet, debossed with ‘AC’ on both sides and a score line on one side.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>AUGMENTIN</em> is an antibiotic agent with a notably broad-spectrum of activity against the commonly occurring bacterial pathogens in general practice and hospital.&nbsp; The betalactamase inhibitory action of clavulanate extends the spectrum of amoxicillin to embrace a wider range of organisms, including many resistant to other beta-lactam antibiotics.</p><p><em>AUGMENTIN</em> should be used in accordance with local official antibiotic-prescribing guidelines and local susceptibility data.</p><p><em>AUGMENTIN</em> oral presentations for twice daily dosing, are indicated for short-term treatment of bacterial infections at the following sites:</p><p><em>Upper respiratory tract infections (including ENT) </em>e.g. recurrent tonsillitis, sinusitis, otitis media.</p><p><em>Lower respiratory tract infections </em>e.g. acute exacerbation of chronic obstructive pulmonary disease (AECOPD)/ acute exacerbation of chronic bronchitis (AECB), lobar and bronchopneumonia.</p><p><em>Genito-urinary tract infections </em>e.g. cystitis, urethritis, pyelonephritis.</p><p><em>Skin and soft tissue infections,</em> e.g. boils, abscesses, cellulitis, wound infections.</p><p><em>Bone and joint infections</em> e.g. osteomyelitis.</p><p><em>Dental infections</em> e.g. dentoalveolar abscess</p><p><em>Other infections </em>e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis.</p><p>Susceptibility to <em>AUGMENTIN</em> will vary with geography and time (see <em>Pharmacological Properties, Pharmacodynamics </em>for further information).&nbsp; Local susceptibility data should be consulted where available, and microbiological sampling and susceptibility testing performed where necessary.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmaceutical form: Film-coated tablets</p><p>Dosage depends on the age and renal function of the patient and the severity of the infection.</p><p>To minimise potential gastrointestinal intolerance, administer at the start of a meal. The absorption of<strong><em> </em></strong>AUGMENTIN is optimised when taken at the start of a meal<strong><em>. </em></strong></p><p>Treatment should not be extended beyond 14 days without review.</p><p>Therapy can be started parenterally and continued with an oral preparation.</p><p>Tablets should be swallowed whole without chewing. If required, tablets may be broken in half and swallowed without chewing.</p><p>AUGMENTIN tablets are not recommended in children of 12 years and under.&nbsp;</p><p>Adults and Children over 12 years</p><p>The usual recommended daily dosage is:</p><p><strong><em>&nbsp;</em></strong></p><table border="0" cellspacing="0" cellpadding="0" style="width:543px"><tbody><tr><td style="vertical-align:top"><p><strong><em>&nbsp;</em></strong></p></td><td style="vertical-align:top"><p><em>&nbsp;</em></p></td></tr><tr><td style="vertical-align:top"><p>Mild - Moderate infections<em> </em></p></td><td style="vertical-align:top"><p>One AUGMENTIN 625 mg tablet every 12 hours.</p></td></tr><tr><td style="vertical-align:top"><p>Severe infections</p></td><td style="vertical-align:top"><p>One AUGMENTIN 1 g tablet every 12 hours.</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>Renal Impairment<!--[if supportFields]><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_c7b7e862-ea7e-43dd-a8a4-8cdbf2bc78c3 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>No adjustment in dose is required in patients with creatinine clearance (CrCl) greater than 30 mL/min. The AUGMENTIN 1g tablet should only be used in patients with a creatinine clearance (CrCl) rate of more than 30 mL/min.</p><table border="0" cellspacing="0" cellpadding="0" style="width:577px"><tbody><tr><td style="vertical-align:top"><p>CrCl 10-30 mL/min&nbsp;</p></td><td style="vertical-align:top"><p>One AUGMENTIN 625 mg tablet every 12 hours.</p></td></tr><tr><td style="vertical-align:top"><p>CrCl &lt; 10 mL/min</p></td><td style="vertical-align:top"><p>One AUGMENTIN 625 mg tablet every 24 hours.</p></td></tr><tr><td style="vertical-align:top"><p>Haemodialysis</p></td><td style="vertical-align:top"><p>One AUGMENTIN 625 mg tablet every 24 hours, plus</p><p>a further one tablet during dialysis, to be repeated at the end of dialysis (as serum concentrations of both amoxicillin and clavulanic acid are decreased).</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>Hepatic Impairment <!--[if supportFields]><span
style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_b35c1a82-793d-4587-a2c9-30e5eb5e677b \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>Administer with caution; monitor hepatic function at regular intervals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AUGMENTIN is contra-indicated in patients with a history of hypersensitivity to betalactams, e.g. penicillins and cephalosporins. 
 
AUGMENTIN is contra-indicated in patients with a previous history of AUGMENTIN associated jaundice/hepatic dysfunction. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Before initiating therapy with <em>AUGMENTIN,</em> careful enquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins, or other allergens.</p><p>Serious and occasionally fatal hypersensitivity reactions (including anaphylactoid and severe cutaneous adverse reactions) have been reported in patients on penicillin therapy.&nbsp; These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity (see Contra-indications). Hypersensitivity reactions can also progress to Kounis syndrome, a serious allergic reaction that can result in myocardial infarction. Presenting symptoms of such reactions can include chest pain occurring in association with an allergic reaction to AUGMENTIN ES (see Undesirable effects). Drug-induced enterocolitis syndrome (DIES) has been reported mainly in children receiving AUGMENTIN ES (see Undesirable effects). DIES is an allergic reaction with the leading symptom of protracted vomiting (1-4 hours after medicinal product administration) in the absence of allergic skin or respiratory symptoms. Further symptoms could comprise abdominal pain, diarrhoea, hypotension or leucocytosis with neutrophilia. In severe cases, drug-induced enterocolitis syndrome can progress to shock. If an allergic reaction occurs, AUGMENTIN ES therapy should be discontinued and appropriate alternative therapy instituted.</p><p>Serious anaphylactic reactions require immediate emergency treatment with adrenaline. Oxygen, intravenous (i.v.) steroids and airway management, including intubation may also be required.</p><p><em>AUGMENTIN</em> should be avoided if infectious mononucleosis is suspected since the occurrence of a morbilliform rash has been associated with this condition following the use of amoxicillin.</p><p><strong><em>&nbsp;</em></strong></p><p>Prolonged use may also occasionally result in overgrowth of non-susceptible organisms.</p><p>Pseudomembranous colitis has been reported with the use of antibiotics and may range in severity from mild to life-threatening. Therefore, it is important to consider its diagnosis in patients who develop diarrhoea during or after antibiotic use. If prolonged or significant diarrhoea occurs or the patient experiences abdominal cramps, treatment should be discontinued immediately and the patient investigated further.</p><p>&nbsp;</p><p>Abnormal prolongation of prothrombin time (increased INR) has been reported rarely in patients receiving <em>AUGMENTIN </em>and oral anticoagulants.&nbsp; Appropriate monitoring should be undertaken when anticoagulants are prescribed concurrently.&nbsp; Adjustments in the dose of oral anticoagulants may be necessary to maintain the desired level of anticoagulation.</p><p>Changes in liver function tests have been observed in some patients receiving <em>AUGMENTIN.</em> The clinical significance of these changes is uncertain.&nbsp; <em>AUGMENTIN</em> should be used with caution in patients with evidence of hepatic dysfunction.</p><p>&nbsp;</p><p>Cholestatic jaundice, which may be severe, but is usually reversible, has been reported rarely. Signs and symptoms may not become apparent for up to six weeks after treatment has ceased.&nbsp;</p><p>In patients with renal impairment <em>AUGMENTIN</em> dosage should be adjusted as recommended in the <em>Dosage and Administration</em> section.</p><p>In patients with reduced urine output, crystalluria (including acute renal injury) has been observed very rarely, predominantly with parenteral therapy.&nbsp; During the administration of high doses of amoxicillin, it is advisable to maintain adequate fluid intake and urinary output in order to reduce the possibility of amoxicillin crystalluria. In patients with bladder catheters, a regular check of patency should be maintained (see Undesirable effects and Overdose).Interaction with other medicinal products and other forms of interaction <!--[if supportFields]><span
style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_728af6c8-3ae6-4cee-9415-39f6817bac49 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>Concomitant use of probenecid is not recommended. Probenecid decreases the renal tubular secretion of amoxicillin. Concomitant use with <em>AUGMENTIN</em> may result in increased and prolonged blood levels of amoxicillin, but not of clavulanic acid.</p><p>Concomitant use of allopurinol during treatment with amoxicillin can increase the likelihood of allergic skin reactions. There are no data on the concomitant use of <em>AUGMENTIN</em><strong> </strong>and allopurinol.</p><p>In common with other antibiotics, <em>AUGMENTIN</em> may affect the gut flora, leading to lower oestrogen reabsorption and reduced efficacy of combined oral contraceptives.</p><p>In the literature, there are rare cases of increased international normalised ratio in patients maintained on acenocoumarol or warfarin and prescribed a course of amoxicillin.&nbsp; If coadministration is necessary, the prothrombin time or international normalised ratio should be carefully monitored with the addition or withdrawal of <em>AUGMENTIN</em>.</p><p>In patients receiving mycophenolate mofetil, reduction in pre-dose concentration of the active metabolite mycophenolic acid of approximately 50% has been reported following commencement of oral amoxicillin plus clavulanic acid. The change in pre-dose level may not accurately represent changes in overall MPA exposure.</p><p>Penicillins may reduce the excretion of methotrexate causing a potential increase in toxicity.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Concomitant use of probenecid is not recommended. Probenecid decreases the renal tubular secretion of amoxicillin. Concomitant use with <em>AUGMENTIN</em> may result in increased and prolonged blood levels of amoxicillin, but not of clavulanic acid.</p><p>Concomitant use of allopurinol during treatment with amoxicillin can increase the likelihood of allergic skin reactions. There are no data on the concomitant use of <em>AUGMENTIN</em><strong> </strong>and allopurinol.</p><p>In common with other antibiotics, <em>AUGMENTIN</em> may affect the gut flora, leading to lower oestrogen reabsorption and reduced efficacy of combined oral contraceptives.</p><p>In the literature, there are rare cases of increased international normalised ratio in patients maintained on acenocoumarol or warfarin and prescribed a course of amoxicillin.&nbsp; If coadministration is necessary, the prothrombin time or international normalised ratio should be carefully monitored with the addition or withdrawal of <em>AUGMENTIN</em>.</p><p>In patients receiving mycophenolate mofetil, reduction in pre-dose concentration of the active metabolite mycophenolic acid of approximately 50% has been reported following commencement of oral amoxicillin plus clavulanic acid. The change in pre-dose level may not accurately represent changes in overall MPA exposure.</p><p>Penicillins may reduce the excretion of methotrexate causing a potential increase in toxicity.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy Category B: Reproduction studies in animals (mice and rats at doses up to 10 times the human dose) with orally and parenterally administered <em>AUGMENTIN</em> have shown no teratogenic effects.&nbsp; In a single study in women with pre-term, premature rupture of the foetal membrane (pPROM), it was reported that prophylactic treatment with <em>AUGMENTIN</em> may be associated with an increased risk of necrotising enterocolitis in neonates. As with all medicines, use should be avoided in pregnancy, especially during the first trimester, unless considered essential by the physician.</p><p>&nbsp;</p><p><em>AUGMENTIN</em> may be administered during the period of lactation.&nbsp; With the exception of the risk of sensitisation, associated with the excretion of trace quantities in breast milk, there are no known detrimental effects for the breast-fed infant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse effects on the ability to drive or operate machinery have not been observed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Data from large clinical trials was used to determine the frequency of very common to rare undesirable effects. The frequencies assigned to all other undesirable effects (i.e., those occurring at &lt;1/10,000) were mainly determined using post-marketing data and refer to a reporting rate rather than a true frequency.&nbsp;</p><p>&nbsp;</p><p>The following convention has been used for the classification of frequency :-&nbsp;</p><p>very common <strong><em>&ge;</em></strong>1/10 common <em>&ge;</em>1/100 <em>to</em> &lt;1/10&nbsp; uncommon <em>&ge;</em>1/1000 <em>to</em> &lt;1/100&nbsp; rare <em>&ge;</em>1/10,000 <em>to</em> &lt;1/1000&nbsp;</p><p>very rare &lt;1/10,000.&nbsp;&nbsp;</p><p><strong>Infections and infestations&nbsp;&nbsp; </strong></p><p>Common&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mucocutaneous candidiasis</p><p>Blood and lymphatic system disorders <!--[if supportFields]><span
style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_0be9edd5-be61-43c3-842a-3b773133be8c \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>Rare&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible leucopenia (including neutropenia) and thrombocytopenia<strong>&nbsp; </strong></p><p>Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible agranulocytosis and haemolytic anaemia. Prolongation of bleeding time and prothrombin time.</p><p>Immune system disorders <!--[if supportFields]><span style='mso-element:
field-begin'></span><span style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_eea6136f-30dc-4962-896f-34abde2da5b1 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>Very rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Angioneurotic oedema, anaphylaxis (see <em>Special warnings and precautions for use</em><!--[if supportFields]><i><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_3c14edfc-63b6-46bb-9590-f665ebfc5d7f \* MERGEFORMAT <span
style='mso-element:field-separator'></span></i><![endif]--><em>&nbsp;</em><!--[if supportFields]><i><span
style='mso-element:field-end'></span></i><![endif]-->), serum sickness-like syndrome, hypersensitivity vasculitis (see also <em>Skin and subcutaneous tissue disorders</em>).</p><p>Nervous system disorders<!--[if supportFields]><span style='mso-element:
field-begin'></span> DOCVARIABLE vault_nd_9379e185-5e57-4f88-b865-fe900801c946
\* MERGEFORMAT <span style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>Uncommon&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness, headache&nbsp;</p><p>Very rare&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible hyperactivity, aseptic meningitis,<strong><s> </s></strong>&nbsp;convulsions. Convulsions may occur in patients with impaired renal function or in those receiving high doses.</p><p>Not known &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aseptic meningitis<strong> </strong></p><p><strong>Cardiac disorders </strong></p><p>Very rare Kounis syndrome (see Special warnings and precautions for use).</p><p>&nbsp;</p><p><strong>Gastrointestinal disorders</strong></p><p><strong><em>Adults</em></strong></p><p>Very common&nbsp;&nbsp;&nbsp;&nbsp; Diarrhoea</p><p>Common&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nausea, vomiting</p><p><strong><em>Children</em></strong></p><p>Common&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diarrhoea, nausea, vomiting</p><p>All populations<!--[if supportFields]><span style='font-weight:normal'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_d1bcdbb2-bee6-4c16-9707-87a9bd5f035d \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-weight:normal'><span style='mso-element:field-end'></span></span><![endif]--></p><p>Nausea is more often associated with higher oral dosages. If gastrointestinal reactions are evident, they may be reduced by taking <em>AUGMENTIN</em> at the start of a meal.</p><p>Uncommon &nbsp;&nbsp;&nbsp; Indigestion&nbsp;</p><p>Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Antibiotic-associated colitis<strong> (</strong>including pseudomembranous colitis and haemorrhagic colitis).</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Black hairy tongue</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Superficial tooth discolouration has been reported very rarely in children.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Good oral hygiene may help to prevent tooth discolouration as it</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; can usually be removed by brushing.</p><p>Not known &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Drug-induced enterocolitis syndrome (see Special warnings and precautions for use), Pancreatitis acute.</p><p>Hepatobiliary disorders <!--[if supportFields]><span style='mso-element:
field-begin'></span><span style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_7fa530d5-0e14-40f9-af31-9f4b17298a68 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>Uncommon &nbsp;&nbsp;&nbsp; A moderate rise in AST and/or ALT has been noted in patients treated with beta-lactam class antibiotics, but the significance of these findings is unknown.</p><p>Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatitis and cholestatic jaundice<strong>.</strong> These events have been noted with other penicillins and cephalosporins.&nbsp;</p><p>Hepatic events have been reported predominantly in males and elderly patients and may be associated with prolonged treatment. These events have been very rarely reported in children.</p><p>&nbsp;</p><p>Signs and symptoms usually occur during or shortly after treatment but in some cases may not become apparent until several weeks after treatment has ceased.&nbsp; These are usually reversible. Hepatic events may be severe and in extremely rare circumstances, deaths have been reported. These have almost always occurred in patients with serious underlying disease or taking concomitant medications known to have the potential for hepatic effects.</p><p><strong>&nbsp;</strong></p><p>Skin and subcutaneous tissue disorders <!--[if supportFields]><span
style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_2600a3cd-d8a1-4743-8ebb-82236352f752 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>Uncommon&nbsp; &nbsp;&nbsp;&nbsp; Skin rash, pruritus, urticaria&nbsp;</p><p>Rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Erythema multiforme</p><p>Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stevens-Johnson syndrome, toxic epidermal necrolysis, bullous exfoliative-dermatitis, acute generalised exanthemous pustulosis (AGEP)<strong><em>, </em></strong>drug reaction with eosinophilia and systemic symptoms (DRESS), and symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) (baboon syndrome) (see also <em>Immune system disorders</em>).</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If any hypersensitivity dermatitis reaction occurs, treatment should be discontinued.</p><p>Not Known&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Linear IgA disease.</p><p>Renal and urinary disorders <!--[if supportFields]><span
style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_2d8e62b9-0f7a-4989-ba87-ad98064b4a02 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interstitial nephritis</p><p>Not known &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Crystalluria (including acute renal injury) (see Overdose).</p><p><strong>To report any side effect(s): </strong></p><p><strong><em>Kingdom of Saudi Arabia</em></strong><strong><em> </em></strong></p><p><strong>-The National Pharmacovigilance centre (NPC) </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reporting hotline: 19999</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa<u> </u></p><p><strong>-GSK - Head Office, Jeddah </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: saudi.safety@gsk.com<u> </u></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O Box 55850, Jeddah 21544, Saudi Arabia. &nbsp;</p><p>&nbsp;</p><p><strong>For any information about this medicinal product, please contact: </strong></p><p><strong>GSK - Head Office, Jeddah </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: gcc.medinfo@gsk.com<u> </u></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O. Box 55850, Jeddah 21544, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Gastrointestinal symptoms and disturbance of the fluid and electrolyte balances may be evident. Gastrointestinal symptoms may be treated symptomatically, with attention to the water/ electrolyte balance. <strong>&nbsp;</strong></p><p>Amoxicillin crystalluria, in some cases leading to renal failure, has been observed (see <em>Special warnings and Precautions for use</em>).</p><p>&nbsp;</p><p><em>AUGMENTIN</em> can be removed from the circulation by haemodialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ATC code: J01CR02.</p><p>Pharmacotherapeutic group: Combinations of penicillins, incl. beta-lactamase inhibitors. Resistance to many antibiotics is caused by bacterial enzymes which destroy the antibiotic before it can act on the pathogen. The clavulanate in <em>AUGMENTIN</em> anticipates this defence mechanism by blocking the beta -lactamase enzymes, thus rendering the organisms susceptible to amoxicillin&rsquo;s rapid bactericidal effect at concentrations readily attainable in the body. Clavulanate by itself has little antibacterial activity; however, in association with amoxicillin as <em>AUGMENTIN</em> it produces an antibiotic agent of broad spectrum with wide application in hospital and general practice.</p><p>&nbsp;</p><p><u>In the list below, organisms are categorised according to their <em>in vitro</em> susceptibility to</u><!--[if supportFields]><span
style='font-weight:normal'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_2a822c83-39ec-4d57-8979-4b9c6298eedb \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-weight:normal'><span style='mso-element:field-end'></span></span><![endif]--></p><p><em><u>AUGMENTIN</u></em><u>.</u>&nbsp;&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" align="left"><tbody><tr><td style="vertical-align:top"><p><strong><em>In vitro</em> susceptibility of micro-organisms to <em>AUGMENTIN</em></strong></p><p>&nbsp;</p><p>Where clinical efficacy of <em>AUGMENTIN</em> has been demonstrated in clinical trials this is indicated with an asterisk (*).</p><p>&nbsp;</p><p>Organisms that do not produce beta-lactamase are identified (with <sup>&dagger;</sup>).&nbsp; If an isolate is susceptible to amoxicillin, it can be considered susceptible to <em>AUGMENTIN. </em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Commonly susceptible species</strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-positive aerobes:</u></p></td></tr><tr><td style="vertical-align:top"><p><em>Bacillius anthracis </em></p><p><em>Enterococcus faecalis </em></p><p><em>Listeria monocytogenes </em></p><p><em>Nocardia asteroides </em></p><p><em>Streptococcus pyogenes*</em><sup>&dagger;</sup><em> </em></p><p><em>Streptococcus agalactiae*</em><sup>&dagger;</sup><em> </em></p><p><em>Streptococcus</em> spp. (other beta -hemolytic)<em> *</em><sup>&dagger;</sup></p><p><em>Staphylococcus aureus</em> (methicillin susceptible)*</p><p><em>Staphylococcus saprophyticus</em> (methicillin susceptible)</p><p>Coagulase negative staphylococcus (methicillin susceptible)&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-negative aerobes:</u></p><p><em>Bordetella pertussis </em></p><p><em>Haemophilus influenzae* </em></p><p><em>Haemophilus parainfluenzae</em></p><p><em>Helicobacter pylori </em></p><p><em>Moraxella catarrhalis* </em></p><p><em>Neisseria gonorrhoeae<sup> </sup></em></p><p><em>Pasteurella multocida </em></p><p><em>Vibrio cholerae</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Other:</u></p><p><em>Borrelia burgdorferi<sup> </sup></em></p><p><em>Leptospira ictterohaemorrhagiae </em></p><p><em>Treponema pallidum</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Gram positive anaerobes:</u></p><p><em>Clostridium </em>spp.</p><p><em>Peptococcus niger </em></p><p><em>Peptostreptococcus magnus </em></p><p><em>Peptostreptococcus micros </em></p><p><em>Peptostreptococcus</em> spp.</p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-negative anaerobes:</u></p></td></tr><tr><td style="vertical-align:top"><p><em>Bacteroides fragilis </em></p><p><em>Bacteroides</em> spp.</p><p><em>Capnocytophaga</em> spp.</p><p><em>Eikenella corrodens </em></p><p><em>Fusobacterium nucleatum </em></p><p><em>Fusobacterium</em> spp.</p><p><em>Porphyromonas</em> spp.</p><p><em>Prevotella</em> spp.</p></td></tr><tr><td style="vertical-align:top"><p><strong>Species for which acquired resistance may be a problem</strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-negative aerobes:</u></p><p><em>Escherichia coli* </em></p><p><em>Klebsiella oxytoca </em></p><p><em>Klebsiella pneumoniae* Klebsiella</em> spp.</p><p><em>Proteus mirabilis </em></p><p><em>Proteus vulgaris </em></p><p><em>Proteus</em> spp.</p><p><em>Salmonella</em> spp.</p><p><em>Shigella </em>spp.&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-positive aerobes:</u></p><p><em>Corynebacterium</em> spp.<sup> </sup></p><p><em>Enterococcus faecium&nbsp; </em></p><p><em>Streptococcus pneumoniae*</em><sup>&dagger;<em> </em></sup></p><p>Viridans group streptococcus</p></td></tr><tr><td style="vertical-align:top"><p><strong>Inherently resistant organisms</strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-negative aerobes:</u></p><p><em>Acinetobacter</em> spp. <em>Citrobacter freundii Enterobacter</em> spp.</p><p><em>Hafnia alvei </em></p><p><em>Legionella pneumophila </em></p><p><em>Morganella morganii Providencia spp. </em></p><p><em>Pseudomonas spp. </em></p><p><em>Serratia spp. </em></p><p><em>Stenotrophomas maltophilia </em></p><p><em>Yersinia enterolitica</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Others: </u></p><p><em>Chlamydia pneumoniae </em></p><p><em>Chlamydia psittaci </em></p><p><em>Chlamydia spp.&nbsp; </em></p><p><em>Coxiella burnetti </em></p><p><em>Mycoplasma spp.</em></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The pharmacokinetics of the two components of <em>AUGMENTIN</em> are closely matched. Peak serum levels of both occur about 1 hour after oral administration. Absorption of <em>AUGMENTIN</em> is optimised at the start of a meal.</p><p>Doubling the dosage of <em>AUGMENTIN</em> approximately doubles the serum levels achieved.</p><p>Both clavulanate and amoxicillin have low levels of serum binding; about 70% remains free in the serum</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No further information of relevance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>AUGMENTIN contains sodium starch glycolate, magnesium stearate (E572), colloidal</p><p>silica, microcrystalline cellulose, titanium dioxide (E171), hydroxypropyl methylcellulose, polyethylene glycol, dimeticone (silicone oil).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The expiry date is indicated on the packaging.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not take after the expiry date shown on the pack.</p><p>Store at below 25&deg;C, in a dry place in the original packaging to protect from moisture.</p><p>Refer to pack for storage temperature.</p><p>For AUGMENTIN tablet packs with a storage temperature up to 25&deg;C, use tablets within 30 days of opening (see also Instructions for Use/Handling).</p><p>AUGMENTIN tablet packs contain desiccant sachets. Do not remove or eat.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>AUGMENTIN tablets are suppled in a carton containing blister packs. Each blister pack is stored within a sealed pouch, with a desiccant sachet.<br /><br />Not all presentations are available in every country.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Blister pouches contain a desiccant sachet; do not remove or eat. Discard any opened and unused tablets after storing as directed in the Special Precautions for Storage section.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p>Trademarks are owned by or licensed to the GSK group of companies&nbsp;</p><p>&copy; 2023 GSK, all rights reserved.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Manufactured by:  
SmithKline Beecham plc.* Worthing, UK 

Packed & MAH: 
Glaxo Saudi Arabia Ltd.* Jeddah, Kingdom of Saudi Arabia 
*member of GlaxoSmithKline group of companies 
 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Version number: GDS29/IPI16

Date of issue: 07 September 2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>